Statement re : Posting of Circular to Shareholders
CHESNARA plc (the "Company")
3 July 2009
Circular posted to Shareholders
Further to the announcement made by the Company on 17 April 2009 concerning the
Acquisition (as defined below) the Company has today posted a circular to its
shareholders convening an Extraordinary General Meeting of the Company to be
held on 20 July 2009 at 11.00 a.m. at the offices of Panmure Gordon (UK)
Limited, 155 Moorgate, London EC2M 6XB (the "EGM").
An ordinary resolution will be proposed at the EGM to approve the acquisition
of the entire issued share capital of Moderna Försäkringar Liv AB (the
"Acquisition").
The circular will shortly be available for inspection at the UK Listing
Authority's Document Viewing Facility, which is situated at: Financial Services
Authority, 25 The North Colonnade, Canary Wharf, London E14 5HS. In addition, a
copy of the circular will shortly be available on the Company's website,
www.chesnara.co.uk, or can be inspected at the Company's registered office at
Harbour House, Portway, Preston, Lancashire PR2 2PR.
For further information please contact:
Chesnara plc: +44 (0)7799 407519
Graham Kettleborough, Chief Executive Officer
Cubitt Consulting: +44 (0)20 7367 5106
Michael Henman
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.